Zinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugs

HIV Medicine

Volumn 13, Issue 5, 2012, Pages 297-303

  Ceperuelo Mallafre V ^a,b   Escote X ^a,c   Vilades C ^a   Peraire, J ^a   Domingo, P ^d   Solano, E ^a   Sirvent, J J ^a   Pastor, R ^a   Tinahones, F ^b,e   Leal, M ^f   Richart, C ^a   Vendrell, J ^a,c   Vidal, F ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^e Virgen de la Victoria Clinic Hospital   (Spain)

^f HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antiretroviral drugs; Dyslipidaemia; HIV; Lipodystrophy; Metabolic syndrome; Zinc alpha 2 glycoprotein

Indexed keywords

ADIPOCYTOKINE; ANTIRETROVIRUS AGENT; FATTY ACID BINDING PROTEIN 4; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; ZINC ALPHA 2 GLYCOPROTEIN;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INSULIN RESISTANCE; LIPODYSTROPHY; MAJOR CLINICAL STUDY; METABOLIC DISORDER; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOSITY; ADULT; AGED; AGED, 80 AND OVER; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CARRIER PROTEINS; CHOLESTEROL; DYSLIPIDEMIAS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLYCOPROTEINS; HIV INFECTIONS; HIV-1; HIV-ASSOCIATED LIPODYSTROPHY SYNDROME; HUMANS; MALE; MIDDLE AGED;

EID: 84859426366     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00976.x     Document Type: Article

References (36)

1. Moreno S, Miralles C, Negredo E etal. Disorders of body fat distribution in HIV-infected patients. AIDS Rev 2009; 11: 126-134.
2. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352: 48-62.
3. Tsiodras S, Perelas A, Wanke C etal. The HIV-1/HAART associated metabolic syndrome - novel adipokines, molecular associations and therapeutic implications. J Infect 2010; 61: 101-113.
4. Sankalé JL, Tong Q, Hadigan CM etal. Regulation of adiponectin in adipocytes upon exposure to HIV-1. HIV Med 2006; 7: 268-274.
5. Kosmiski LA, Bacchetti P, Kotler DP etal. Relationship of fat distribution with adipokines in human immunodeficiency virus infection. J Clin Endocrinol Metab 2008; 93: 216-224.
6. Lindegaard B, Keller P, Bruunsgaard H etal. Low plasma level of adiponectin is associated with stavudine treatment and lipodystrophy in HIV-infected patients. Clin Exp Immunol 2004; 135: 273-279.
7. Sweeney LL, Brennan AM, Mantzoros CS. The role of adipokines in relation to HIV lipodystrophy. AIDS 2007; 21: 895-904.
8. Marrades MP, Martínez JA, Moreno-Aliaga MJ. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 2008; 64: 61-66.
9. Selva DM, Lecube A, Hernández C etal. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance. J Clin Endocrinol Metab 2009; 94: 4499-4507.
10. Ceperuelo-Mallafré V, Näf S, Escoté X etal. Circulating and adipose tissue gene expression of zinc-alpha2-glycoprotein in obesity: its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat. J Clin Endocrinol Metab 2009; 94: 5062-5069.
11. Gong FY, Zhang SJ, Deng JY etal. Zinc-alpha2 glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond) 2009; 33: 1023-1030.
12. Stejskal D, Karpísek M, Reutová H etal. Determination of serum zinc-alpha-2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 2008; 41: 313-316.
13. Saumoy M, López-Dupla M, Veloso S etal. The IL-6 system in HIV-1-infection and in HAART-related fat redistribution syndromes. AIDS 2008; 22: 893-896.
14. Saumoy M, Veloso S, Alonso-Villaverde C etal. PPAR gamma polymorphism in HIV-1-infected patients with HAART-related lipodystrophy. Curr HIV Res 2009; 7: 533-540.
15. Veloso S, Olona M, Peraire J etal. No relationship between TNF-alpha genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV-1-infected patients: a case-control study and a meta-analysis. AIDS Res Hum Retroviruses 2011; 27: 143-152.
16. Escoté X, Megia A, López-Dupla M etal. A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy. HIV Med 2011; 12: 428-437.
17. Escoté X, Miranda M, Veloso S etal. Lipodystrophy and insulin resistance in combination antiretroviral treated HIV-1-infected patients: implication of resistin. J Acquir Immune Defic Syndr 2011; 57: 16-23.
18. Carr A, Samaras K, Thorisdottir A etal. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: a cohort study. Lancet 1999; 353: 2093-2099.
19. Hadigan C, Meigs JB, Corcoran C etal. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis 2001; 32: 130-139.
20. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination. JAMA 2002; 287: 356-359.
21. Matthews DR, Hosker JP, Rudenski AS etal. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
22. Auguet T, Vidal F, López-Dupla M etal. A study on the TNF-alpha system in Caucasian Spanish patients with alcoholic liver disease. Drug Alcohol Depend 2008; 92: 91-99.
23. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
24. Burgi W, Schmid K. Preparation and properties of Zn-A2-glycoprotein of normal human plasma. J Biol Chem 1961; 236: 1066-1074.
25. Bing C, Bao Y, Jenkins J etal. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 2004; 101: 2500-2505.
26. Bao Y, Bing C, Hunter L etal. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 2005; 579: 41-47.
27. Mracek T, Ding Q, Tzanavari T etal. The adipokine zinc-alpha2-glycoprotein (ZAG) is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf) 2010; 72: 334-341.
28. Flint OP, Noor MA, Hruz PW etal. The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications. Toxicol Pathol 2009; 37: 65-77.
29. Minami R, Yamamoto M, Takahama S etal. Comparison of the influence of four classes of HIV antiretrovirals on adipocyte differentiation: the minimal effect of raltegravir and atazanavir. J Infect Chemother 2011; 17: 183-188.
30. Villarroya F, Domingo P, Giralt M. Lipodystrophy in HIV-1-infected patients: lessons for obesity research. Int J Obes 2007; 31: 1763-1776.
31. Olofsson LE, Olsson B, Lystig T etal. Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids. Metabolism 2010; 59: 1316-1318.
32. Russell ST, Zimmerman TP, Domin BA etal. Induction of lipolysis in vitro and loss of body fat in vivo by zinc-a2-glycoprotein. Biochim Biophys Acta 2004; 1636: 59-68.
33. Russell ST, Tisdale MJ. Antidiabetic properties of zinc-alpha2-glycoprotein in ob/ob mice. Endocrinology 2010; 151: 948-957.
34. Tisdale MJ. Zinc-alpha2-glycoprotein in cachexia and obesity. Curr Opin Support Palliat Care 2009; 3: 288-293.
35. Verghese PB, Arrese EL, Soulages JL. Stimulation of lipolysis enhances the rate of cholesterol efflux to HDL in adipocytes. Mol Cell Biochem 2007; 302: 241-248.
36. Yeung DC, Lam KS, Wang Y, Tso AW, Xu A. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab 2009; 94: 2531-2536.